USPTO Art Unit 1687 Prosecution Statistics

Art Unit Information

Art Unit: 1687
Group: 1680
Tech Center: 1600
Total Cases: 303
Last Active: July 2024

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18785864PREDICTING mRNA PROPERTIES USING LARGE LANGUAGE TRANSFORMER MODELSJuly 2024March 2025Allow811YesNo
18613618METHODS FOR USING MOSAICISM IN NUCLEIC ACIDS SAMPLED DISTAL TO THEIR ORIGINMarch 2024December 2024Allow911YesNo
18407997CHEMICAL COMPUTATION GRAPHSJanuary 2024November 2024Allow1011YesNo
18523709System of Predicting Sensitivity of Klebsiella against Cefoxitin and MethodNovember 2023May 2025Abandon1841YesNo
18500890MICROSATELLITE INSTABILITY DETECTION IN CELL-FREE DNANovember 2023February 2025Allow1621NoNo
18372402METHODS AND SYSTEMS FOR ANNOTATING GENOMIC DATASeptember 2023February 2025Abandon1720YesNo
18469290METHODS AND SYSTEMS FOR DETECTING INSERTIONS AND DELETIONSSeptember 2023April 2025Abandon1920NoNo
18465093METHODS OF CLASSIFYING AND TREATING PATIENTSSeptember 2023February 2025Abandon1820YesNo
18460671GENOME GRAPH ANALYSIS METHOD, DEVICE AND MEDIUM BASED ON IN-MEMORY COMPUTINGSeptember 2023February 2025Abandon1820NoNo
18364554Classifier Apparatus With Decision Support ToolAugust 2023June 2025Allow2210YesNo
18347986COMPUTATIONAL MODELING OF LOSS OF FUNCTION BASED ON ALLELIC FREQUENCYJuly 2023March 2025Allow2010NoNo
18339887METHODS AND SYSTEMS FOR DETECTING INSERTIONS AND DELETIONSJune 2023January 2025Abandon1910NoNo
18198763SEQUENCING METHODSMay 2023November 2024Allow1821YesNo
18174019METHOD FOR ASSESSING DRUG-RESISTANT STENOTROPHOMONAS MALTOPHILIA AND DRUG-RESISTANT STENOTROPHOMONAS MALTOPHILIA ASSESSING SYSTEMFebruary 2023May 2025Abandon2711NoNo
18171360METHOD FOR DIAGNOSING CANCER AND PREDICTING CANCER TYPE BY USING TERMINAL SEQUENCE MOTIF FREQUENCY AND SIZE OF CELL-FREE NUCLEIC ACID FRAGMENTFebruary 2023June 2025Allow2841YesNo
18169750METHOD FOR DIAGNOSING CANCER AND PREDICTING TYPE OF CANCER BASED ON SINGLE NUCLEOTIDE VARIANT IN CELL-FREE DNAFebruary 2023April 2025Allow2631YesNo
18167803Methods and Systems for Analyzing Nucleic Acid MoleculesFebruary 2023November 2024Abandon2121NoNo
18163138METHODS AND SYSTEMS FOR DETECTING COLORECTAL CANCER VIA NUCLEIC ACID METHYLATION ANALYSISFebruary 2023May 2025Allow2841YesNo
18091965DEEP LEARNING MODEL PREDICTION METHOD OF DRUG IC50 BASED ON MOLECULAR STRUCTURE AND GENE EXPRESSIONDecember 2022October 2024Abandon2220YesNo
18056656Methods and Systems for Analyzing Nucleic Acid MoleculesNovember 2022November 2024Abandon2430YesNo
17901826DIAGNOSTIC TOOL FOR SCREENING THE IMPACT OF PRODUCT INGREDIENTS FOR UROGENITAL MICROBIOMES THERAPIESSeptember 2022March 2025Abandon3041NoNo
17813535CROP MONITORING SYSTEM AND METHODJuly 2022December 2024Abandon2810NoNo
17556434SYSTEMS AND METHODS FOR IDENTIFYING RARE CELLSDecember 2021February 2025Allow3812YesNo
17449022PREDICTION OF INTERFERENCE WITH HOST IMMUNE RESPONSE SYSTEM BASED ON PATHOGEN FEATURESSeptember 2021December 2024Abandon3820YesNo
17482135Methods and System for the Reconstruction of Drug Response and Disease Networks and Uses ThereofSeptember 2021October 2024Allow3720NoNo
17593240METHOD AND SYSTEM FOR MAPPING READ SEQUENCES USING A PANGENOME REFERENCESeptember 2021April 2025Allow4310NoNo
17395566Mitochondrial DNA Quality ControlAugust 2021July 2024Allow3520YesNo
17426058METHODJuly 2021June 2025Allow4720NoNo
17382472SYSTEMS AND METHODS FOR DETERMINING A PHYSIOLOGICAL PROFILE USING GENETIC INFORMATIONJuly 2021February 2024Abandon3180YesNo
17381917VARIANT PATHOGENICITY SCORING AND CLASSIFICATION AND USES THEREOFJuly 2021May 2025Abandon4630YesNo
17374000SYSTEMS AND METHODS FOR DETERMINING NUCLEIC ACIDSJuly 2021November 2024Allow4021YesNo
17352046SYSTEMS AND METHODS FOR USING MULTISCALE DATA FOR VARIABLE, PATHWAY, AND COMPOUND DETECTIONJune 2021May 2025Abandon4721NoNo
17351884ASSOCIATING PEDIGREE SCORES AND SIMILARITY SCORES FOR PLANT FEATURE PREDICTIONJune 2021July 2025Abandon4830YesNo
17347261Kobophenol A for the treatment of Corona Virus 2 (SARS-CoV-2) infectionJune 2021April 2025Abandon4610NoNo
17312950CLOSED-LOOP ARTIFICIAL PANCREAS SYSTEM BASED ON WEARABLE MONITORING METHODJune 2021November 2024Allow4210NoNo
17343305SYSTEM AND METHOD FOR MOLECULAR DYNAMICS ANALYSISJune 2021May 2025Abandon4801NoNo
17295393USE OF NATURAL-ABUNDANCE STABLE ISOTOPES AND DNA GENOTYPING FOR IDENTIFYING BIOLOGICAL PRODUCTSMay 2021March 2025Abandon4601NoNo
17320976HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY DETECTIONMay 2021November 2024Allow4210NoNo
17293418METHODS OF TREATING CANCER USING TUBULIN BINDING AGENTSMay 2021May 2025Abandon4801NoNo
17315977SYSTEMS AND METHODS OF PROCESSING IMAGES TO DETERMINE PATIENT-SPECIFIC PLAQUE PROGRESSION BASED ON THE PROCESSED IMAGESMay 2021April 2025Allow4710YesNo
17239118SYSTEM FOR EVALUATING SENSITIVITY TO ANTI-CANCER AGENT AND A COMPUTER READABLE MEDIUM STORING PROGRAMS EXECUTING AN EVALUATING METHODApril 2021June 2024Abandon3730YesNo
17288476SYSTEM AND METHOD FOR DETERMINING DEAMIDATION AND IMMUNOGENICITY OF POLYPEPTIDESApril 2021March 2025Abandon4710NoNo
17287956Omics Detection of Nonhomologous End Joining Repair Site SignaturesApril 2021December 2024Abandon4410NoNo
17237144SYSTEMS AND METHODS FOR SIMULATION OF OCCLUDED ARTERIES AND OPTIMIZATION OF OCCLUSION-BASED TREATMENTSApril 2021April 2025Allow4810NoNo
17237730METHOD, APPARATUS AND SYSTEM FOR TESTING BLOODApril 2021January 2025Abandon4511NoNo
17233029SYSTEMS AND METHODS FOR VISUALIZING ADAPTIVE IMMUNE CELL CLONOTYPING DATAApril 2021March 2025Abandon4730YesNo
17232056ARTIFICIAL INTELLIGENCE-BASED ANALYSIS OF PROTEIN THREE-DIMENSIONAL (3D) STRUCTURESApril 2021September 2024Allow4130YesNo
17222970SYSTEMS AND METHODS FOR IDENTIFYING AND TREATING NEURODEGENERATIVE DISEASEApril 2021June 2025Abandon5021NoNo
17211003TAU PROTEIN ACCUMULATION PREDICTION APPARATUS USING MACHINE LEARNING AND TAU PROTEIN ACCUMULATION PREDICTION METHOD USING THE SAMEMarch 2021May 2025Abandon5040NoNo
17201589SYSTEMS AND METHODS FOR VESSEL REACTIVITY TO GUIDE DIAGNOSIS OR TREATMENT OF CARDIOVASCULAR DISEASEMarch 2021April 2025Allow4910NoNo
17198822METHOD FOR PREDICTING DISEASE STATE, THERAPEUTIC RESPONSE, AND OUTCOMES BY SPATIAL BIOMARKERSMarch 2021May 2025Abandon5011NoNo
17195582Methods for Detecting Analytes in Excreta in an Analytical ToiletMarch 2021March 2025Abandon4810NoNo
17273577MICROBIOME-BASED TRACKING SYSTEM AND METHODS RELATING THERETOMarch 2021December 2024Abandon4521NoNo
17191004POLYGENIC RISK SCORE MODIFIES RISK OF CORONARY ARTERY DISEASE CONFERRED BY LOW-DENSITY LIPOPROTEIN CHOLESTEROLMarch 2021May 2025Abandon5110NoNo
17272517METHOD FOR ASSESSING GENOME ALIGNMENT BASISMarch 2021January 2025Abandon4710NoNo
17184451GENETIC AND GENEALOGICAL ANALYSIS FOR IDENTIFICATION OF BIRTH LOCATION AND SURNAME INFORMATIONFebruary 2021January 2025Abandon4610NoNo
17176151Knowledge Distillation and Gradient Pruning-Based Compression of Artificial Intelligence-Based Base CallerFebruary 2021March 2025Allow4930YesNo
17171768Dropout Detection in Continuous Analyte Monitoring Data During Data ExcursionsFebruary 2021June 2025Allow5230YesNo
17266689DETERMINING PROTEIN DISTANCE MAPS BY COMBINING DISTANCE MAPS CROPSFebruary 2021March 2025Allow4911YesNo
17266115FREE ENERGY PERTURBATION COMPUTATION SCHEDULING METHOD USED IN HETEROGENEOUS CLUSTER ENVIRONMENTFebruary 2021October 2024Abandon4510NoNo
17166449SYSTEMS AND METHODS FOR MICROWAVE JAMMING OF MOLECULAR RECOGNITIONFebruary 2021November 2024Allow4610NoNo
17265642Visual Representations of Peptide SequencesFebruary 2021April 2025Allow5120YesNo
17265708MACHINE LEARNING FOR DETERMINING PROTEIN STRUCTURESFebruary 2021March 2025Abandon4930YesYes
17165189CROP MONITORING SYSTEM AND METHODFebruary 2021October 2024Abandon4510NoNo
17153164SYSTEMS AND METHODS FOR ALIGNMENT-BASED PRE-TRAINING OF PROTEIN PREDICTION MODELSJanuary 2021December 2024Abandon4730YesNo
17151936DEVELOPMENT OF NOVEL AUTOMATED SCREENING METHOD FOR DETECTION OF FVIII INHIBITORSJanuary 2021April 2025Allow5111NoNo
17146535SYSTEMS AND METHODS FOR MODELLING A HUMAN SUBJECTJanuary 2021June 2025Abandon5320YesNo
17140253Quantum Computing SystemJanuary 2021June 2025Abandon5320NoNo
17257208CODON OPTIMIZATIONDecember 2020May 2025Abandon5330YesNo
17118421ENHANCED PROTEIN STRUCTURE PREDICTION USING PROTEIN HOMOLOG DISCOVERY AND CONSTRAINED DISTOGRAMSDecember 2020May 2025Abandon5311NoNo
16972535TECHNOLOGY ADAPTED TO ENABLE IMPROVED COLLECTION OF INVOLUNTARY EYELlD MOVEMENT PARAMETERS, INCLUDING COLLECTION OF EYELlD MOVEMENT PARAMETERS TO SUPPORT ANALYSIS OF NEUROLOGICAL FACTORSDecember 2020January 2025Abandon4911NoNo
17108259PREDICTING ANIMAL TESTING MEASUREMENT LEVELSDecember 2020May 2025Abandon5420YesNo
17107662METHODS AND SYSTEMS FOR DNA DATA STORAGENovember 2020February 2025Abandon5110NoNo
17095970ANTIBODY SELECTION APPARATUS AND METHODSNovember 2020June 2025Allow5530YesNo
17095206SYSTEMS AND METHODS FOR USE OF KNOWN ALLELES IN READ MAPPINGNovember 2020May 2025Allow5510NoNo
17051796METHOD AND APPARATUS FOR CLASSIFYING SUBJECTS BASED ON TIME SERIES PHENOTYPIC DATAOctober 2020May 2025Abandon5411NoNo
17050030METHOD FOR PREDICTING THE MELTING TEMPERATURE OF OLIGONUCLEOTIDEOctober 2020May 2025Allow5530NoNo
17049667MOLECULAR TYPING OF MULTIPLE MYELOMA AND APPLICATIONOctober 2020October 2024Allow4811NoNo
17048062A THREE-PROTEIN PROTEOMIC BIOMARKER FOR PROSPECTIVE DETERMINATION OF RISK FOR DEVELOPMENT OF ACTIVE TUBERCULOSISOctober 2020December 2024Abandon5011NoNo
17070668GENE EXPRESSION SIGNATURE OF HYPERPROGRESSIVE DISEASE (HPD) IN PATIENTS AFTER ANTI-PD-1 IMMUNOTHERAPYOctober 2020March 2025Allow5321YesNo
17047320ULTRA-SENSITIVE DETECTION OF CANCER BY ALGORITHMIC ANALYSISOctober 2020June 2025Abandon5630YesNo
16948915SYSTEMS AND METHODS FOR IDENTIFYING SEQUENCE VARIATIONOctober 2020November 2024Abandon4920NoNo
17061590METHODS FOR PRODUCING BIOTHERAPEUTICS WITH INCREASED STABILITY BY SEQUENCE OPTIMIZATIONOctober 2020June 2025Abandon5620NoNo
17039647Command CenterSeptember 2020September 2024Allow4720YesNo
17043693METHOD FOR DETERMINING ANDROGEN AND ANTI-ANDROGEN EFFECTS ON SUBSTANCESSeptember 2020February 2025Abandon5320NoNo
17042765BIOMARKER ANALYSIS FOR HIGH-THROUGHPUT DIAGNOSTIC MULTIPLEX DATASeptember 2020April 2025Abandon5521NoNo
17041836Methods for Predicting Genomic Variation Effects on Gene TranscriptionSeptember 2020August 2024Allow4720YesNo
17041620ACTIVE LEARNING MODEL VALIDATIONSeptember 2020March 2025Abandon5320NoNo
17024656METHOD FOR BUILDING PREDICTIVE MODEL OF MICROORGANISM-DERIVED DISSOLVED ORGANIC NITROGEN IN WASTEWATERSeptember 2020February 2025Abandon5320NoNo
17017441GENETIC ANALYSIS METHODSeptember 2020June 2025Abandon5701NoNo
16976421SYSTEMS AND METHODS FOR PREDICTIVE NETWORK MODELING FOR COMPUTATIONAL SYSTEMS, BIOLOGY AND DRUG TARGET DISCOVERYAugust 2020February 2025Abandon5421NoNo
16976056ULTRA-SENSITIVE DETECTION OF CIRCULATING TUMOR DNA THROUGH GENOME-WIDE INTEGRATIONAugust 2020September 2024Abandon4931YesNo
16975962Covariant Neural Network Architecture for Determining Atomic PotentialsAugust 2020November 2024Abandon5120NoNo
16970327URINE MARKERS AND FORMULA FOR DIAGNOSING OVERACTIVE BLADDER DISORDERAugust 2020September 2024Allow4920YesNo
16985765PREDICTIVE MONITORING OF THE GLUCOSE-INSULIN ENDOCRINE METABOLIC REGULATORY SYSTEMAugust 2020August 2024Allow4930YesNo
16942222KINEMATIC MODELING OF BIOCHEMICAL PATHWAYSJuly 2020April 2025Abandon5620YesNo
16940380NORMALIZING CHROMOSOMES FOR THE DETERMINATION AND VERIFICATION OF COMMON AND RARE CHROMOSOMAL ANEUPLOIDIESJuly 2020March 2025Allow5620YesNo
16920641TECHNIQUES FOR BIAS CORRECTION IN SEQUENCE DATAJuly 2020September 2024Allow5081YesNo
16920514METHOD AND SYSTEM FOR PERSONALIZED, MOLECULAR BASED HEALTH MANAGEMENT AND DIGITAL CONSULTATION AND TREATMENTJuly 2020December 2024Abandon5321YesNo
16919577IDENTIFICATION, CHARACTERIZATION, AND QUANTITATION OF CRISPR-INTRODUCED DOUBLE-STRANDED DNA BREAK REPAIRSJuly 2020July 2024Allow4840YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1687.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
2
(40.0%)
Examiner Reversed
3
(60.0%)
Reversal Percentile
96.3%
Higher than average

What This Means

With a 60.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
32
Allowed After Appeal Filing
9
(28.1%)
Not Allowed After Appeal Filing
23
(71.9%)
Filing Benefit Percentile
24.3%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 28.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Art Unit 1687 - Prosecution Statistics Summary

Executive Summary

Art Unit 1687 is part of Group 1680 in Technology Center 1600. This art unit has examined 303 patent applications in our dataset, with an overall allowance rate of 68.6%. Applications typically reach final disposition in approximately 53 months.

Comparative Analysis

Art Unit 1687's allowance rate of 68.6% places it in the 25% percentile among all USPTO art units. This art unit has a below-average allowance rate compared to other art units.

Prosecution Patterns

Applications in Art Unit 1687 receive an average of 3.07 office actions before reaching final disposition (in the 100% percentile). The median prosecution time is 53 months (in the 0% percentile).

Strategic Considerations

When prosecuting applications in this art unit, consider the following:

  • The art unit's allowance rate suggests a more challenging examination environment compared to the USPTO average.
  • With more office actions than average, plan for multiple rounds of prosecution.
  • The median prosecution time is longer than average and should be factored into your continuation and client communication strategies.
  • Review individual examiner statistics within this art unit to identify examiners with particularly favorable or challenging prosecution patterns.

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.